Protective drugs in cancer therapy: Optimal clinical testing and future directions
- 1 March 1982
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 8 (3-4) , 513-517
- https://doi.org/10.1016/0360-3016(82)90673-3
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Phase I clinical trials of WR-2721 with alkylating agent chemotherapyInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Clinical trials of WR-2721 with radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 1982
- In vitro studies on the absorption of WR-2721 by tumors and normal tissuesInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Circumvention of the tumor membrane barrier to WR-2721 absorption by reduction of drug hydrophilicityInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Radiobiological and Biochemical Studies of Thiophosphate Radioprotective Compounds Related to CysteamineRadiation Research, 1971